Skip to main content

Peer Review reports

From: Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts

Original Submission
17 Jun 2010 Submitted Original manuscript
2 Jul 2010 Reviewed Reviewer Report - Rolf Brekken
30 Aug 2010 Reviewed Reviewer Report - Esther Guzman
6 Sep 2010 Author responded Author comments - David Hedley
Resubmission - Version 2
6 Sep 2010 Submitted Manuscript version 2
10 Sep 2010 Reviewed Reviewer Report - Rolf Brekken
10 Sep 2010 Reviewed Reviewer Report - Esther Guzman
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
28 Sep 2010 Editorially accepted
28 Sep 2010 Article published 10.1186/1471-2407-10-515

You can find further information about peer review here.

Back to article page